The severity of brain damage determines bone marrow stromal cell therapy efficacy in a traumatic brain injury model-Reference-Cited by-同舟云学术

The severity of brain damage determines bone marrow stromal cell therapy efficacy in a traumatic brain injury model

Published:2012-05 Issue:5 Volume:72 Page:1203-1212
ISSN:0022-5282
Container-title:Journal of Trauma and Acute Care Surgery
language:en
Short-container-title:

Author:

Bonilla Celia,Zurita Mercedes,Otero Laura,Aguayo Concepción,Rico Miguel A.,Vaquero Jesús

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Surgery

Reference52 articles.

1. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome.;Lu;Neuroreport,2001

2. Immunophenotype characterization of rat mesenchymal stromal cells.;Harting;Cytotherapy,2008

3. . Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.;Horwitz;Cytotherapy,2005

4. . Inflammation after trauma: microglial activation and traumatic brain injury.;Ramlackhansingh;Ann Neurol,2011

5. Delayed intralesional transplantation of bone marrow stromal cells increases endogenous neurogenesis and promotes functional recovery after severe traumatic brain injury.;Bonilla;Brain Inj,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review and meta-analysis of preclinical studies testing mesenchymal stromal cells for traumatic brain injury;npj Regenerative Medicine;2021-10-29

2. Cell-Based Therapies for Traumatic Brain Injury: Therapeutic Treatments and Clinical Trials;Biomedicines;2021-06-10

3. Recent advances in the treatment of traumatic brain injury with autologous and non-autologous multipotent stem and progenitor cells: preclinical models and clinical trials;Folia Neuropathologica;2021

4. Evaluation of Evidence: Stem Cells as a Treatment Option for Traumatic Brain Injury;eLS;2020-02-17

5. Platelet-rich plasma-derived scaffolds increase the benefit of delayed mesenchymal stromal cell therapy after severe traumatic brain injury;Cytotherapy;2018-03